Nondrug therapies that might have been dismissed 30 years ago are now the sorts of treatments physicians are turning to instead of overused treatments like surgical procedures, opioids, and injections, said Daniel Clauw, MD, professor of anesthesiology, medicine (rheumatology), and psychiatry; director of translational research; and director of the Center for Chronic Pain and Fatigue Research.
Nondrug therapies that might have been dismissed 30 years ago are now the sorts of treatments physicians are turning to instead of overused treatments like surgical procedures, opioids, and injections, said Daniel Clauw, MD, professor of anesthesiology, medicine (rheumatology), and psychiatry; director of translational research; and director of the Center for Chronic Pain and Fatigue Research.
Transcript
How has pain management for patients with fibromyalgia evolved? Are opioids still beneficial for these patients, since they experience chronic pain, or are we starting to find alternatives so we can taper these patients off opioids?
So, in the last 20 years or so I think physicians have understood that fibromyalgia is a real disease, the approval of 3 different drugs by the FDA helped a lot because those companies had education programs that went along with their drug approvals, but over that period of time I think there has been a gradual acceptance that there is a number of drug therapies that can be helpful in fibromyalgia.
But we also have seen more and more literature suggesting that nondrug therapies—we’ve known forever that cognitive behavioral therapy and exercise were helpful treatments for fibromyalgia, but it’s really been in the last 5 to 10 years that it’s become clear that a much broader set of nondrug therapies are helpful, not just in fibromyalgia but in any chronic pain condition: things like mindfulness, yoga, tai chi, biofeedback chiropractic manipulation, acupuncture, acupressure. These are things that when I was trained 30 or so years ago, we were fairly dismissive of in the US healthcare systems that these things were not effective.
And now 30 years later the pendulum has swung away from the surgical procedures, the opioids, the injections that we overuse in the United States and we’re starting to more and more embrace the use of these nondrug therapies.
FIT Completion, Yield Rates in CRC Screening Similar After New Screening Guidelines
October 22nd 2024Patients were found to have similar completion and yield rates for the fecal immunochemical test (FIT) at both 45 years and 50 years, making screening for colorectal cancer (CRC) effective in younger patients.
Read More
Building Trust, Breaking Barriers: Health Care Leaders Tackle Primary Care Challenges
August 8th 2024On this episode of Managed Care Cast, we're talking with the chief medical officers of CVS Health and Aetna, as well as CVS Health's chief health equity officer, about primary and preventive care engagement, the impact of telehealth, and the role of trust in patient-provider relationships.
Listen
Frameworks for Advancing Health Equity: Health Equity by Design
July 23rd 2024Melissa Clarke, MD, CMQ, the chief health equity officer at Elevance Health, explains "Health Equity by Design" and how Elevance Health is committed to ensuring a personalized and intentional approach for all its members.
Listen
Delayed Diagnoses, Oxygen Therapy Use Linked to Worse Outcomes in Patients With Fibrotic ILD
October 21st 2024Posters presented at the CHEST 2024 annual meeting revealed that delays in diagnosing fibrotic interstitial lung disease (ILD) can negatively impact overall survival, while supplemental oxygen therapy may exacerbate clinical burdens through increased rates of acute exacerbations and hospitalizations.
Read More
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
October 21st 2024Examining care transitions in hospitalized patients revealed lower diagnostic error rates compared with traditional methods, highlighting the effectiveness of this approach in identifying diagnostic challenges.
Read More